Information on importing to Ukraine of antiviral medicines containing active substances oseltamivir and zanamivir

Опубліковано 07.02.2020 о 16:24

 

 

According to the data base of the SMDC and according to the Resolution of the Cabinet of Ministers of Ukraine of 14.09.2005, No. 902 “On approval of the procedure for conducting state control of the quality of medicinal products imported into Ukraine” (hereinafter – Procedure) during the period since 01.09.2019 till 07.02.2020 the following antiviral medicines containing active substance oseltamivir have been submitted for quality control

Importer

Medicine

Producer

Series

Quantity

Roche Ukraine, LLC

TAMIFLU

capsules

Hoffmann-La Roch Ltd, Switzerland

UA/3189/02/03

M1065B03

M1062B07

10 558

20 572

Total:

31 130

 

Roche Ukraine, LLC

TAMIFLU

powder

Hoffmann-La Roch Ltd, Switzerland

UA/3189/01/02

B8060B02

B8064B02

B8062B02

500

660

650

Total:

1 810

S PHARMA LLC

FLUCAP

capsules

Hetero Labs Limited (India)

UA/17009/01/03

Е191848

Е191666А

9 615

2 565

Total:

12 180

Macleods Pharmaceuticals Ltd

SELTAVIR

capsules

Macleods Pharmaceuticals Ltd (India)

UA/17704/01/03

BOJ9901А

25 355

 

 All the above mentioned medicines have passed the state quality control in accordance to the Procedure and the Conclusions on quality recognition  have been issued. 

Meanwhile, according to the SMDC data base, medicines containing active substance zanamivir were not submitted  for quality control during the period between 01.09.2019 and 07.02.2020

Sale of imported medicinal products hasn’t been restricted or prohibited by the SMDC during the period between 01.09.2019 and 07.02.2020

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Print button Версія для друку

Попередня

State Service of Ukraine on Medicines and Drugs Control and Armed Forces of Ukraine establish close cooperation

Наступна

The European Medicines Agency (EMA) celebrates 25th anniversary caring about public and animal health